Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.8M
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
+602K
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
+$13.8M
-
Put/Call ratio
-
0.08
-
Number of buys
-
118
-
Number of sells
-
-109
-
Price
-
$49.43
Significant Holders of RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) as of Q3 2024
267 filings reported holding RXST - RxSight, Inc. - Common Stock, $0.001 par value per share as of Q3 2024.
RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
of 43.8M outstanding shares and own 77.52% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (3.92M shares), BlackRock, Inc. (2.79M shares), VANGUARD GROUP INC (2.29M shares), BANK OF AMERICA CORP /DE/ (1.75M shares), FMR LLC (1.2M shares), Artisan Partners Limited Partnership (1.17M shares), LORD, ABBETT & CO. LLC (1.05M shares), Invesco Ltd. (988K shares), STATE STREET CORP (818K shares), and GEODE CAPITAL MANAGEMENT, LLC (817K shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.